Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice

American Journal of Industrial Medicine

Volumn 53, Issue 12, 2010, Pages 1197-1206

  Soffritti, Morando ^a   Belpoggi, Fiorella ^a   Manservigi, Marco ^a   Tibaldi, Eva ^a   Lauriola, Michelina ^a   Falcioni, Laura ^a   Bua, Luciano ^a  

^a Istituto Ramazzini   (Italy)

Author keywords

Artificial sweeteners; Aspartame; Cancers; Carcinogenicity; Hepatocarcinomas; Lung adenocarcinomas; Prenatal exposure; Rats; Swiss mice

Indexed keywords

ASPARTAME; CARCINOGEN; SWEETENING AGENT;

AGE; ANIMAL; ANIMAL DISEASE; ARTICLE; CATERING SERVICE; FEMALE; LIVER TUMOR; LUNG TUMOR; MALE; MOUSE; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; TIME;

AGE FACTORS; ANIMALS; ASPARTAME; CARCINOGENS; FEMALE; FOOD SUPPLY; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROPORTIONAL HAZARDS MODELS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SWEETENING AGENTS; TIME FACTORS;

EID: 78649538952     PISSN: 02713586     EISSN: 10970274     Source Type: Journal    
DOI: 10.1002/ajim.20896     Document Type: Article

References (38)

1. Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LMJ, Geha RF, Hertelendy Z, Kostner A, Leon AS, Liepa GU, McMartin KE, Mendnhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK. 2002. Intake of aspartame vs the acceptable daily intake. Regul Toxicol Pharmacol 35: S13-S16.
2. Decreto Legislativo 116. 1992. Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian]. Suppl Ordinario Gazz Ufficiale 40: 5-25.
3. Dixon D, Herbert RA, Kissling GE, Brix AE, Miller RA, Maronpot RR. 2008. Summary of chemically induced pulmonary lesions in the National Toxicology Program (NTP) toxicology and carcinogenesis studies. Toxicol Pathol 36: 428-439.
4. European Food Safety Authority (EFSA). 2006. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC) on a request from the Commission related to a new long-term carcinogenicity study on aspartame. Question number EFSA-Q-2005-122. Adopted on 3 May 2006. EFSA J 356: 1-44.
5. Food and Drug Administration (FDA). 1981. Aspartame: Commissioner's final decision. Fed Reg 46: 38285-38308.
6. Food and Drug Administration (FDA). 1983. Food additives permitted for direct addition to food for human consumption: Aspartame. Fed Reg 48: 31376-31382.
7. Food and Drug Administration (FDA). 1996. Food additives permitted for direct addition to food for human consumption: Aspartame. Fed Reg 61: 33654-33656.
8. 01 study). Park Forest South, IL: Pathotox Publishers, Inc., p 121-138.
9. Hahn FF, Gigliotti A, Hutt JA. 2007. Comparative oncology of lung tumors. Toxicol Pathol 35: 130-135.
10. Haschemeyer RH, Haschemeyer AEV. 1973. Proteins. New York: John Wiley & Sons, p 11-30.
11. Haseman J. 1992. Value of historical controls in the interpretation of rodent neoplasm data. Drug Inf J 26: 191-200.
12. Haseman J. 1995. Data analysis: Statistical analysis and use of historical control data. Regul Toxicol Pharmacol 21: 52-59.
13. Haseman J, Huff JE, Boorman GA. 1984. Use of historical control data in carcinogenicity studies in rodents. Toxicol Pathol 12: 126-135.
14. Haseman J, Melnick R, Tomatis L, Huff J. 2001. Carcinogenesis bioassays: Study duration and biological relevance. Food Chem Toxicol 39(7): 739-744.
15. Hazardous Substances Data Bank. 2005. TOXNET: Toxicological Data Network. Available: [accessed August 3, 2005].
16. Huff J. 2002. Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program. In tribute to Cesare Maltoni and David Rall. Ann N Y Acad Sci 982: 208-230.
17. Huff J. 2003. Absence of carcinogenic activity in Fischer rats and B6C3F1 mice following 103-week inhalation exposures to toluene. Int J Occup Environ Health 9(2): 138-146.
18. Huff J, Jacobson MF, Davis DL. 2008. The limits of two-year bioassay exposure regimens for identifying chemical carcinogens. Environ Health Perspect 116(11): 1439-1442.
19. Huff J, Hejtmancik M, Eastin W. 2010. Carcinogenic activity of industrial grade mixed xylenes. Environ Health Perspect (in press).
20. International Agency for Research on Cancer (IARC). 1973. Transplacental induction of tumors and malformations in rats treated with some chemical carcinogens. IARC Sci Publ 4: 100-111.
21. Maltoni C, Ciliberti A, Pinto C, Soffritti M, Belpoggi F, Menarini L. 1997. Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels and major gasoline aromatics on rats. Ann N Y Acad Sci 837: 15-52.
22. Maronpot RR. 2009. Biological basis of differential susceptibility to hepatocarcinogenesis among mouse strains. J Toxicol Pathol 22: 11-33.
23. Mattews DM. 1984. Absorption of peptides, amino acids, and their methylated derivatives. In: Stegink LD, Filer LJ, Jr., editors. Aspartame physiology and biochemistry. New York: Dekker, p 29-46.
24. Mazur RH. 1984. Discovery of aspartame. In: Stegink LD, Filer LJ, Jr., editors. Aspartame physiology and biochemistry. New York: Dekker, p 3-9.
25. Metzler DE. 1977. Biochemistry. New York: Academic Press, p 90-107.
26. Molinary SV. 1984. Preclinical studies of aspartame in nonprimate animals. In: Stegink LD, Filer LJ, Jr., editors. Aspartame physiology and biochemistry. New York: Dekker, p 289-306.
27. National Toxicology Program (NTP). 2005. Genetically Modified Model Report. Toxicology Studies of Aspartame (CAS NO. 22839-47-0) in Genetically Modified (FVB Tg.AC Hemizygous) and B6.129-Cdkn2atm1Rdp (N2) Deficient Mice and Carcinogenicity Studies of Aspartame in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Feed Studies). NTP GMM1. National Toxicology Program, Research Triangle Park. Available at.
28. Olney JW, Farber NB, Spitznagel E, Robins LN. 1996. Increasing brain tumor rates: Is there a link to aspartame? J Neuropathol Exp Neurol 55: 1115-1123.
29. Pritchard JB, French JE, Davis BJ, Haserman JK. 2003. The role of transgenic mouse models in carcinogen identification. Environ Health Perspect 111: 444-454.
30. Ranney RE, Opperman JA, Maldoon E, McMahon FG. 1976. Comparative metabolism of aspartame in experimental animals and humans. J Toxicol Environ Health 2: 441-451.
31. Soffritti M, Belpoggi F, Minardi F, Bua L, Maltoni C. 1999. Mega-experiments to identify and assess diffuse carcinogenic risks. Ann N Y Acad Sci 895: 34-55.
32. Soffritti M, Belpoggi F, Minardi F, Maltoni C. 2002. Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results. Ann N Y Acad Sci 982: 26-45.
33. Soffritti M, Belpoggi F, Padovani M, Lauriola M, Degli Esposti D, Minardi F. 2004. Life-time carcinogenicity bioassays of toluene given bay stomach tube to Sprague-Dawley rats. Eur J Oncol 9: 91-102.
34. Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L. 2005. Aspartame induces lymphomas and leukaemias in rats. Eur J Oncol 10: 107-116.
35. Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A. 2006. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ Health Perspect 114: 379-385.
36. Soffritti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M. 2007. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ Health Perspect 115: 1293-1297.
37. Soffritti M, Belpoggi F, Esposti DD, Falcioni L, Bua L. 2008. Consequences of exposure to carcinogens beginning during developmental life. Basic Clin Pharmacol Toxicol 102(2): 118-124.
38. Trocho C, Pardo R, Rafecas I, Virgili J, Remesar X, Fernandez-Lopez JA, Alemany M. 1998. Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci 63: 337-349.